PLUS1
13.99
0.29 (2.12%)
0.29 (2.12%)
Upgrade to Real-Time
Afterhours
| Volume | 212,307 |
|
|||||
| News | - | ||||||
| Day High | 14.12 | Low High |
|||||
| Day Low | 13.56 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.29 | 2.12% | 13.99 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.62 | 13.56 | 14.12 | 13.99 | 13.70 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,004 | 212,307 | $ 13.97 | $ 2,965,723 | - | 10.8001 - 39.08 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:15 | 14 | $ 13.99 | USD |
Period:
Draw Mode:
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 368.32M | 26.33M | 19.42M | $ 57.03M | $ -13.83M | -0.72 | -6.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 897.23k | 7.30% |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.18 | 14.12 | 12.95 | 13.37 | 152,520 | 0.81 | 6.15% |
| 1 Month | 18.13 | 19.64 | 10.8001 | 12.99 | 377,089 | -4.14 | -22.84% |
| 3 Months | 17.46 | 20.82 | 10.8001 | 13.87 | 155,617 | -3.47 | -19.87% |
| 6 Months | 26.42 | 28.025 | 10.8001 | 15.01 | 89,521 | -12.43 | -47.05% |
| 1 Year | 32.25 | 39.08 | 10.8001 | 19.54 | 66,912 | -18.26 | -56.62% |
| 3 Years | 18.30 | 63.69 | 10.8001 | 25.54 | 68,086 | -4.31 | -23.55% |
| 5 Years | 18.30 | 63.69 | 10.8001 | 25.54 | 68,086 | -4.31 | -23.55% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
